Breaking News

Lonza Upgrades Powder Characterization Capabilities at Tampa Site

New instruments to provide greater understanding of the behavior of powdered drug substance, excipients and blends used to develop new dosage units.

Lonza has enhanced its powder characterization capabilities at its small molecules site in Tampa, FL. The facility has been upgraded to include universal powder flow testing alongside automated particle size and shape analysis capabilities. The addition of new instruments at the site aims to enable a greater understanding of the behavior of powdered drug substances, excipients and blends used in the development of new dosage units. The new powder flow tester can characterize powder flow pr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters